Anna Kock
Impact in
-
- Cancer, Hypoxia, and Metabolism
- NF-κB Signaling Pathways
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in
-
- Neuroblastoma Research and Treatments 8
-
- Cancer, Hypoxia, and Metabolism 3
- NF-κB Signaling Pathways 3
- Co-authors
- Per Kogner (8 shared papers)John Inge Johnsen (6 shared papers)Per‐Johan Jakobsson (4 shared papers)Karin Larsson (4 shared papers)Marina Korotkova (3 shared papers)Marie Arsenian‐Henriksson (3 shared papers)Tommy Martinsson (1 shared paper)Helena Idborg (1 shared paper)
In The Last Decade
Anna Kock
11 papers receiving 310 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 100
- Neurology 99
- Immunology 84
- Oncology 88
- Pharmacology 52
Countries citing papers authored by Anna Kock
This map shows the geographic impact of Anna Kock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kock more than expected).
Fields of papers citing papers by Anna Kock
This network shows the impact of papers produced by Anna Kock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kock. The network helps show where Anna Kock may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Kock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 86 | |
| 2 | 2018 | 62 | |
| 3 | 1992 | 54 | |
| 4 | 2012 | 43 | |
| 5 | 2020 | 22 | |
| 6 | 2016 | 20 | |
| 7 | 2017 | 14 | |
| 8 | 2019 | 8 | |
| 9 | 2014 | 2 | |
| 10 | Localization of sulfapyrazine in cancer tissue upon glucose injection. | 1952 | 1 |
| 11 | [Quality assurance study of rectal cancer]. | 2005 | 1 |
About Anna Kock
Anna Kock is a scholar working on Neurology, Cancer Research, Pharmacology, Immunology and Molecular Biology, having authored 11 papers that have together received 313 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (3 papers), NF-κB Signaling Pathways (3 papers), Inflammatory mediators and NSAID effects (3 papers), interferon and immune responses (1 paper), Clinical practice guidelines implementation (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper) and Chromatin Remodeling and Cancer (1 paper). The work is most often cited by research in Cancer Research (100 citations), Neurology (99 citations), Immunology (84 citations), Oncology (88 citations) and Pharmacology (52 citations). Anna Kock has collaborated with scholars based in Sweden, Germany and Norway. Frequent co-authors include Per Kogner, John Inge Johnsen, Per‐Johan Jakobsson, Karin Larsson, Marina Korotkova, Marie Arsenian‐Henriksson, Tommy Martinsson, Helena Idborg, Filip Bergqvist and Lotta Elfman. Their work appears in journals such as Genes & Development, The Journal of Immunology, Advances in experimental medicine and biology, EBioMedicine and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.